Consolidated Statement Of Profit Or Loss

Astellas Pharma Inc. - Filing #7711337

Concept 2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
1,306,348,000,000 JPY
1,300,316,000,000 JPY
Cost of sales
292,050,000,000 JPY
294,250,000,000 JPY
Gross profit
1,014,299,000,000 JPY
1,006,066,000,000 JPY
Selling, general and administrative expenses
490,263,000,000 JPY
478,330,000,000 JPY
Other income
14,152,000,000 JPY
11,872,000,000 JPY
Other expenses
48,755,000,000 JPY
67,311,000,000 JPY
Operating profit (loss)
243,912,000,000 JPY
213,258,000,000 JPY
Finance income
6,358,000,000 JPY
6,637,000,000 JPY
Finance costs
1,302,000,000 JPY
1,782,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
-1,627,000,000 JPY
-2,419,000,000 JPY
Profit (loss) before tax
248,967,000,000 JPY
218,113,000,000 JPY
Income tax expense
26,702,000,000 JPY
53,434,000,000 JPY
Profit (loss)
JPY
JPY
222,265,000,000 JPY
222,265,000,000 JPY
JPY
JPY
JPY
JPY
JPY
222,265,000,000 JPY
JPY
JPY
JPY
JPY
164,679,000,000 JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
164,679,000,000 JPY
164,679,000,000 JPY
Profit (loss) attributable to
Owners of parent
222,265,000,000 JPY
164,679,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
115.05
81.11
Diluted earnings (loss) per share
114.94
81.02

Talk to a Data Expert

Have a question? We'll get back to you promptly.